Discover

INCY
Incyte Corporation
116.47
1 x 115.01
1 x 118.54
bid
ask
-
0.92
0.78%
09:32 AM
timesize
Ytd17.93%
1y69.05%
117.00
day range
117.00
68.90
52 week range
118.52
Open117.00Prev Close117.39Low117.00High117.00Mkt Cap23.45B
Vol20.22KAvg Vol1.74MEPS7.44P/E15.78Forward P/E15.06
Beta0.76Short Ratio4.72Inst. Own106.64%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning07-2850-d Avg105.37200-d Avg99.851yr Est113.82

INCY News

HALO Inks Deal With INCY to Support Cancer Therapy Development
zacks.com
HALO Inks Deal With INCY to Support Cancer Therapy Development

Halozyme grants ENHANZE rights to Incyte for developing subcutaneous cancer therapy formulations, ai

Incyte (INCY) Reports Next Week: Wall Street Expects Earnings Growth
zacks.com
Incyte (INCY) Reports Next Week: Wall Street Expects Earnings Growth

Incyte (INCY) possesses the right combination of the two key ingredients for a likely earnings beat

benzinga.com
HC Wainwright & Co. Reiterates Buy on Incyte, Maintains $140 Price Target

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Incyte (NASDAQ:INCY) with a Buy and

Bank of New York Mellon Corp Trims Stock Position in Incyte Corporation $INCY
defenseworld.net
Bank of New York Mellon Corp Trims Stock Position in Incyte Corporation $INCY

Bank of New York Mellon Corp lessened its holdings in Incyte Corporation (NASDAQ: INCY) by 1.3% duri

Fifth Third Bancorp Boosts Stock Position in Incyte Corporation $INCY
defenseworld.net
Fifth Third Bancorp Boosts Stock Position in Incyte Corporation $INCY

Fifth Third Bancorp boosted its stake in shares of Incyte Corporation (NASDAQ: INCY) by 145.2% in th

Andra AP fonden Has $24.38 Million Holdings in Incyte Corporation $INCY
defenseworld.net
Andra AP fonden Has $24.38 Million Holdings in Incyte Corporation $INCY

Andra AP fonden lessened its position in Incyte Corporation (NASDAQ: INCY) by 34.6% during the undef

benzinga.com
Halozyme Therapeutics Signs Agreement With Incyte To Mull Additional Subcutaneous Formulations Of IN

Halozyme Therapeutics, Inc. (NASDAQ:HALO) ("Halozyme" or the "Company") today announ

Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA033989 Using its ENHANZE® Technology
prnewswire.com
Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development

Agreement provides Incyte the rights to develop and commercialize ENHANZE® with its mutCALR developm

benzinga.com
Incyte To Present New Phase 1 Solid Tumor Data, Including KRAS G12D and TGFβR2×PD‑1 Programs, At ESM

Rapid oral presentations will highlight new Phase 1 data across Incyte’s solid tumor portfolioBoth I

Incyte Data to Be Highlighted in Four Rapid Oral Presentations at the European Society for Medical Oncology (ESMO) Congress 2026 Support Efforts to Improve Outcomes in Difficult-to-Treat Cancers
businesswire.com
Incyte Data to Be Highlighted in Four Rapid Oral Presentations at the European Society for Medical O

WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte Data to Be Highlighted in Four Rapid Oral Presen

benzinga.com
Barclays Maintains Overweight on Incyte, Raises Price Target to $134

Barclays analyst Etzer Darout maintains Incyte (NASDAQ:INCY) with a Overweight and raises the pri

Incyte Says Early Data Points To Promise For Once-Monthly Preventive Treatment For Inherited Blood Disorder
benzinga.com
Incyte Says Early Data Points To Promise For Once-Monthly Preventive Treatment For Inherited Blood D

Incyte reports Phase 1/2 latarcibart data showing lower bleeding rates and favorable safety in patie

benzinga.com
BMO Capital Maintains Market Perform on Incyte, Raises Price Target to $112

BMO Capital analyst Evan Seigerman maintains Incyte (NASDAQ:INCY) with a Market Perform and raise

benzinga.com
RBC Capital Maintains Sector Perform on Incyte, Raises Price Target to $99

RBC Capital analyst Brian Abrahams maintains Incyte (NASDAQ:INCY) with a Sector Perform and raise

benzinga.com
HC Wainwright & Co. Reiterates Buy on Incyte, Maintains $140 Price Target

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Incyte (NASDAQ:INCY) with a Buy and

benzinga.com
UBS Maintains Neutral on Incyte, Raises Price Target to $113

UBS analyst Ashwani Verma maintains Incyte (NASDAQ:INCY) with a Neutral and raises the price targ

benzinga.com
Incyte Announces EMA CHMP Positive Opinion Recommending Approval Of Opzelura Cream For Moderate Atop

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment opt

benzinga.com
HC Wainwright & Co. Reiterates Buy on Incyte, Maintains $140 Price Target

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Incyte (NASDAQ:INCY) with a Buy and

benzinga.com
Truist Securities Maintains Hold on Incyte, Raises Price Target to $105

Truist Securities analyst Srikripa Devarakonda maintains Incyte (NASDAQ:INCY) with a Hold and rai

Micron To Rally More Than 36%? Here Are 10 Top Analyst Forecasts For Monday
benzinga.com
Micron To Rally More Than 36%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed outlook on top names. See all changes, including upgrades/downgrade

This ConocoPhillips Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
benzinga.com
This ConocoPhillips Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Top Wall Street analysts upgraded APA, INCY, COP, OVV, BWXT stocks with higher price targets. Check

benzinga.com
BMO Capital Upgrades Incyte to Market Perform, Raises Price Target to $94

BMO Capital analyst Evan Seigerman upgrades Incyte (NASDAQ:INCY) from Underperform to Market Perf

Earnings Scheduled For April 28, 2026
benzinga.com
Earnings Scheduled For April 28, 2026

benzinga.com
Adagene Collaborates With Incyte To Evaluate Combination Of Muzastotug And INCA33890 In Patients Wit

Phase 1 study of INCA33890 and muzastotug expected to begin in 2026 in 3L MSS CRC patients with and

Earnings Scheduled For February 10, 2026
benzinga.com
Earnings Scheduled For February 10, 2026

This Incyte Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday
benzinga.com
This Incyte Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday

Nasdaq 100 Hits 26,000, Gold Falls Below $4,000: What's Moving Markets Tuesday?
benzinga.com
Nasdaq 100 Hits 26,000, Gold Falls Below $4,000: What's Moving Markets Tuesday?

Tech stocks hit new highs as the Nasdaq 100 rallies 0.7% midday. Investors eye a Fed rate cut, Trump

Earnings Scheduled For October 28, 2025
benzinga.com
Earnings Scheduled For October 28, 2025

Sanmina, Sarepta Therapeutics, Polaris, Celestica And Other Big Stocks Moving Higher On Tuesday
benzinga.com
Sanmina, Sarepta Therapeutics, Polaris, Celestica And Other Big Stocks Moving Higher On Tuesday

benzinga.com
Earnings Scheduled For July 29, 2025

benzinga.com
Earnings Scheduled For February 10, 2025

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 369 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 148 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  Thursday's session saw 189 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

Stocks That Hit 52-Week Lows On Wednesday

benzinga.com
Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Monday